Work

Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Hemophilia a or B with Inhibitors: Results from explorer4, a Phase 2, Randomized, Open-Label, Controlled Trial

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-122809

Authors: Amy Shapiro, Giancarlo Castaman, Katarina Cepo, Lone Hvitfeldt Poulsen, Christian Hollensen, Tadashi Matsushita, Guy Young, Silva Zupancic-Salek, Victor Jimenez-Yuste

Institutions: Indiana Hemophilia and Thrombosis Center, Azienda Ospedaliero-Universitaria Careggi, Novo Nordisk (Denmark), Aarhus University, Nagoya University Hospital, University of Southern California, Hospital Universitario La Paz

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2982788002

Cites:

Cited by: 4

Related to: 10